pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,340 catalysts · 5,063 phase readout · 2,335 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 21 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×clear all
type
  • phase readout5,063
  • 8k filing2,335
  • earnings283
  • pdufa277
  • phase 2 completion115
  • phase 1 completion53
  • phase 1 2 completion
28
  • phase 1 initiation26
  • phase 0 trial completion22
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06362148: Circulating Tumor DNA in Peripheral T-cell Lymphomas

    Sponsor: University of Aarhus. Phase: . Conditions: Peripheral T-cell Lymphoma, NK/T-Cell Lymphoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06992258: A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

    Sponsor: Criterium, Inc.. Phase: PHASE2. Conditions: Colorectal Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06885658: Effectiveness of Visual Storytelling Intervention on Antibiotic Adherence in UTI Patients

    Sponsor: Xi'an Jiaotong University. Phase: NA. Conditions: Uncomplicated Urinary Tract Infection, Patient With Uncomplicated UTI

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07262658: Cognitive Disparities in Parkinson's Disease

    Sponsor: Duke University. Phase: . Conditions: Parkinson Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06927648: CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA

    Sponsor: AstraZeneca. Phase: . Conditions: Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07126548: A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Prostate Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02372448: Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer Patients

    Sponsor: Centre Hospitalier Universitaire de Nice. Phase: NA. Conditions: Lung Neoplasms

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04815239: Early Intervention for Youth at High Risk for Bipolar Disorder

    Sponsor: University of Pittsburgh. Phase: NA. Conditions: Bipolar Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00001539: A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Lyme Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06217939: Early Intravenous Hydrocortisone in Sepsis

    Sponsor: Siriraj Hospital. Phase: NA. Conditions: Sepsis Severe, Shock, Septic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06537557: Application of an Early In-Hospital Temperature Management Protocol for Heat Stroke Patients

    Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: NA. Conditions: Heat Stroke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03505801: Confirm Rx Insertable Cardiac Monitor SMART Registry

    Sponsor: Abbott Medical Devices. Phase: . Conditions: Cardiac Arrhythmias, Symptoms and Signs, Atrial Fibrillation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03561701: A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

    Sponsor: Mycovia Pharmaceuticals Inc.. Phase: PHASE3. Conditions: Recurrent Vulvovaginal Candidiasis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07622901: Fasting InTervention for Endometrial Cancer

    Sponsor: University of Miami. Phase: NA. Conditions: Endometrial Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07386912: Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -

    Sponsor: Research Center Borstel. Phase: . Conditions: Asthma, COPD, Bacterial Pneumonia, Viral Pneumonia, Tuberculosis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07568639: Multi-Site Cortical Puncture for DOR

    Sponsor: First Affiliated Hospital of Guangxi Medical University. Phase: NA. Conditions: Diminished Ovarian Reserve (DOR)

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06734039: Impact of Anatomy-Based Cochlear Implant Programming on Early Performance

    Sponsor: Med-El Corporation. Phase: NA. Conditions: Hearing Loss, Unilateral, Cochlear Implants, Hearing Loss, Sensorineural, Single-Sided Deafness (SSD), Asymmetric Hearing Loss

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06052839: Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC

    Sponsor: Dan Zandberg. Phase: PHASE2. Conditions: Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07000357: A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

    Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Cardiovascular Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04230512: Assessment of a Hybrid Pump for Vacuum Suspension of Prosthetic Sockets for Persons With Lower Limb Loss to Characterize the Effects of Added Movement on Socket-reaction Torques

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Amputation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07659847: Cardiovascular Assessment 5 Years After MIS-C

    Sponsor: Medical University of Warsaw. Phase: . Conditions: Multisystem Inflammatory Syndrome in Children (MIS-C), SARS-CoV-2 Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07577349: EWSs and 28-Day Mortality in Geriatric ED Patients

    Sponsor: Haseki Training and Research Hospital. Phase: . Conditions: Mortality, Clinical Deterioration, Geriatric Patients, Frailty, Emergency Department Visits

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07481149: Trial of a Virtual Exercise-based Rehabilitation Program to Treat Persistent Chemotherapy-Induced Peripheral Neuropathy (CIPN)

    Sponsor: University Health Network, Toronto. Phase: PHASE3. Conditions: Chemotherapy-induced Peripheral Neuropathy (CIPN)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03570749: A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

    Sponsor: Eli Lilly and Company. Phase: PHASE2. Conditions: Alopecia Areata

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05378347: Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

    Sponsor: Medtronic Cardiovascular. Phase: NA. Conditions: Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06112249: SAFE Workplace Intervention for People With IDD

    Sponsor: Temple University. Phase: NA. Conditions: Communicable Diseases, Prevention, Workplace Intervention

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07329049: The Effect of Inspiratory Muscle Training on Cognitive Functions, Cerebral Oxygenation, and Neurotrophic Factor Level in Patients With Obstructive Sleep Apnea Syndrome

    Sponsor: Istinye University. Phase: NA. Conditions: Obstructive Sleep Apnea Syndrome (OSAS)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06672549: A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

    Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Obesity, Overweight

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03346538: Dose Finding Study of MCI-186 in Acute Ischemic Stroke

    Sponsor: Shionogi. Phase: PHASE2. Conditions: Acute Ischemic Stroke

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03496649: Pubalgia and Adductor Tendinopathies Refractory to Medical Treatment

    Sponsor: University Hospital, Bordeaux. Phase: PHASE2. Conditions: Groin Injury, Tendinopathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07616648: Effects of Opioid Drugs on Sleep and Emotion in Patients With Moderate to Severe Cancer Pain

    Sponsor: First Affiliated Hospital of Zhejiang University. Phase: . Conditions: Moderate to Severe Cancer Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05934747: Aim 3 Particle Swarm Optimization PIGD

    Sponsor: University of Minnesota. Phase: NA. Conditions: Parkinson's Disease and Parkinsonism

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06119581: A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

    Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07613528: Individualized Prolonged Luteal Support After Fresh Embryo Transfer in Women With Low Progesterone

    Sponsor: University Hospital, Montpellier. Phase: PHASE3. Conditions: Pregnancy, Progesterone Supplementation, Low Serum Progesterone

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07612865: People's Hospital of Xinjiang Uygur Autonomous Region

    Sponsor: People's Hospital of Xinjiang Uygur Autonomous Region. Phase: NA. Conditions: Cervical Cancer, Venous Thromboembolism, Lymphedema

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07381465: Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus

    Sponsor: Chinese SLE Treatment And Research Group. Phase: PHASE4. Conditions: Lupus Erythematosus, Systemic

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07431411: Reproductive Health Education, Birth Control and Sexual Quality of Life in Ectopic Pregnancy

    Sponsor: Buket Kömürcü. Phase: NA. Conditions: Ectopic Pregnancy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07396311: Fractional Exhaled Nitric Oxide and Exacerbations of COPD

    Sponsor: Chang Gung Memorial Hospital. Phase: . Conditions: Chronic Obstructive Pulmonary Disease (COPD)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07436611: Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains

    Sponsor: AFT Pharmaceuticals, Ltd.. Phase: PHASE2. Conditions: Port Wine Stains

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06704971: Assessing Cognitive Decline at Home

    Sponsor: Stanford University. Phase: . Conditions: Mild Cognitive Impairment, Mild Dementia, Dementia Alzheimers, Dementia, Memory Impairment, NPS

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05765344: Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function

    Sponsor: Gilead Sciences. Phase: PHASE1. Conditions: Hepatic Impairment, Healthy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07637734: Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)

    Sponsor: Verrica Pharmaceuticals Inc.. Phase: PHASE3. Conditions: Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (HPV), Warts

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05858034: Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older

    Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: HIV, Aging

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05959434: Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD

    Sponsor: Texas A&M University. Phase: PHASE2. Conditions: Posttraumatic Stress Disorder, Alcohol Use Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06626334: Blue Light as an Anti-inflammatory and Analgesic Strategy in Thoracic Trauma

    Sponsor: Rebecca E Kotcher, MD. Phase: NA. Conditions: Rib Fractures, Pain, Acute

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04994132: A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

    Sponsor: Children's Oncology Group. Phase: PHASE3. Conditions: Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma, Metastatic Embryonal Rhabdomyosarcoma, Metastatic Rhabdomyosarcoma, Solid Alveolar Rhabdomyosarcoma, Spindle Cell Rhabdomyosarcoma, Spindle Cell/Sclerosing Rhabdomyosarcoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06827132: Observational Study Evaluate Pathology Practice Use Artificial Intelligence in Patient Suspected Lung and Breast Cancer

    Sponsor: AstraZeneca. Phase: . Conditions: Lung Cancer, Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06786832: Characterization, Treatment, and Long-term Follow-up of Fatigued Patients in Primary Care

    Sponsor: Karolinska Institutet. Phase: NA. Conditions: Fatigue, Fatigue Post Viral, Exhaustion Disorder, Fatigue Symptom, Fatigue Related to Cancer Treatment

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07374198: Effect of Continuous Intraoperative Esketamine Infusion on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Mild-to-Severe Depression

    Sponsor: Chinese PLA General Hospital. Phase: NA. Conditions: Depression, Anxiety, S-ketamine, Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07505563: MiniFlo for Advanced Dupuytren's Disease

    Sponsor: Azienda Ospedaliera Universitaria Integrata Verona. Phase: NA. Conditions: Dupuytren's Disease

    full page →ctgov ↗
    ← prev
    page 91 of 107
    next →